Ambrisentan Tablets Shortage
Last Updated: December 5, 2024
Status: Current
Reason for the Shortage
-
- Apotex has ambrisentan tablets available.
- Cipla has ambrisentan tablets available.
- Mylan has ambrisentan tablets available.
- Sun Pharma has ambrisentan tablets available.
- Teva has ambrisentan tablets available.
- Zydus has ambrisentan tablets available.
- Gilead has Letairis tablets available.
Available Products
-
- Letairis oral tablet, Gilead, 10 mg, bottle, 10 count, NDC 61958-0802-05
- Letairis oral tablet, Gilead, 10 mg, bottle, 30 count, NDC 61958-0802-01
- Letairis oral tablet, Gilead, 5 mg, bottle, 10 count, NDC 61958-0801-05
- Letairis oral tablet, Gilead, 5 mg, bottle, 30 count, NDC 61958-0801-01
- Ambrisentan oral tablet, Apotex, 10 mg, bottle, 30 count, NDC 60505-4553-03
- Ambrisentan oral tablet, Apotex, 5 mg, bottle, 30 count, NDC 60505-4552-03
- Ambrisentan oral tablet, Cipla USA, 10 mg, bottle, 30 count, NDC 69097-0387-02
- Ambrisentan oral tablet, Cipla USA, 5 mg, bottle, 30 count, NDC 69097-0386-02
- Ambrisentan oral tablet, Mylan (Viatris), 10 mg, bottle, 30 count, NDC 00378-4271-93
- Ambrisentan oral tablet, Mylan (Viatris), 5 mg, bottle, 30 count, NDC 00378-4270-93
- Ambrisentan oral tablet, Sun Pharma, 10 mg, bottle, 30 count, NDC 47335-0237-83
- Ambrisentan oral tablet, Sun Pharma, 5 mg, bottle, 30 count, NDC 47335-0236-83
- Ambrisentan oral tablet, Teva, 10 mg, bottle, 30 count, NDC 00591-2406-30
- Ambrisentan oral tablet, Teva, 5 mg, bottle, 30 count, NDC 00591-2405-30
- Ambrisentan oral tablet, Zydus, 10 mg, bottle, 30 count, NDC 70710-1180-03
- Ambrisentan oral tablet, Zydus, 5 mg, bottle, 30 count, NDC 70710-1179-03
Updated
Updated December 5, 2024 by Leslie Jensen, PharmD, Drug Information Specialist. Created May 7, 2024 by Leslie Jensen, PharmD, Drug Information Specialist. © 2024, Drug Information Service, University of Utah, Salt Lake City, UT.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.